Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Nuvectis Pharma, Inc. (NVCT)

Compare
9.53
-0.25
(-2.56%)
At close: 4:00:00 PM EDT
8.70
-0.83
(-8.71%)
After hours: 6:12:03 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for NVCT

Recent News: NVCT

View More
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting
GlobeNewswire 20 days ago
Nuvectis Pharma to Participate in the 37th Annual Roth Conference

Nuvectis Pharma to Participate in the 37th Annual Roth Conference
GlobeNewswire last month

Market News Alert: Nuvectis Pharma’s NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation
Business Wire last month
Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC

Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC
GlobeNewswire last month

Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets
Business Wire last month
Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights

Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights
GlobeNewswire last month
Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option
GlobeNewswire 2 months ago
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock

Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
GlobeNewswire 2 months ago
Nuvectis Pharma Announces Proposed Public Offering of Common Stock

Nuvectis Pharma Announces Proposed Public Offering of Common Stock
GlobeNewswire 2 months ago
Favourable Signals For Nuvectis Pharma: Numerous Insiders Acquired Stock

Favourable Signals For Nuvectis Pharma: Numerous Insiders Acquired Stock
Simply Wall St. 2 months ago
Insiders hold 63% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently

Insiders hold 63% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently
Simply Wall St. 3 months ago
View More

Related Tickers

LXEO Lexeo Therapeutics, Inc.
2.5500
+19.16%
 
ETNB 89bio, Inc.
6.05
+2.20%
 
PRQR ProQR Therapeutics N.V.
1.1900
+0.85%
 
TRVI Trevi Therapeutics, Inc.
6.20
+4.20%
 
GNLX Genelux Corporation
2.4600
+1.65%
 
MTSR Metsera, Inc.
17.16
-5.61%
 
PHAR Pharming Group N.V.
8.16
-2.39%
 
RNAC Cartesian Therapeutics, Inc.
11.97
-7.92%
 
PTGX Protagonist Therapeutics, Inc.
46.95
+4.26%
 
XTLB XTL Biopharmaceuticals Ltd.
1.1300
+2.73%